Works matching IS 03065251 AND DT 2021 AND VI 87 AND IP 4


Results: 59
    1

    Issue highlights.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1633, doi. 10.1111/bcp.14815
    Publication type:
    Article
    2

    Nonmedical use of prescription drugs.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1635, doi. 10.1111/bcp.14797
    By:
    • Cremers, Serge;
    • Wright, Daniel F. B.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 2078, doi. 10.1111/bcp.14619
    By:
    • Rajoli, Rajith K. R.;
    • Pertinez, Henry;
    • Arshad, Usman;
    • Box, Helen;
    • Tatham, Lee;
    • Curley, Paul;
    • Neary, Megan;
    • Sharp, Joanne;
    • Liptrott, Neill J.;
    • Valentijn, Anthony;
    • David, Christopher;
    • Rannard, Steven P.;
    • Aljayyoussi, Ghaith;
    • Pennington, Shaun H.;
    • Hill, Andrew;
    • Boffito, Marta;
    • Ward, Steve A.;
    • Khoo, Saye H.;
    • Bray, Patrick G.;
    • O'Neill, Paul M.
    Publication type:
    Article
    10
    11

    Warfarin dosing algorithms: A systematic review.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1717, doi. 10.1111/bcp.14608
    By:
    • Asiimwe, Innocent G.;
    • Zhang, Eunice J.;
    • Osanlou, Rostam;
    • Jorgensen, Andrea L.;
    • Pirmohamed, Munir
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1890, doi. 10.1111/bcp.14578
    By:
    • Tang, Dan;
    • Yan, Miao;
    • Song, Bai‐li;
    • Zhao, Yi‐chang;
    • Xiao, Yi‐wen;
    • Wang, Feng;
    • Liang, Wu;
    • Zhang, Bi‐kui;
    • Chen, Xi‐jing;
    • Zou, Jian‐jun;
    • Tian, Yi;
    • Wang, Wen‐long;
    • Jiang, Yong‐fang;
    • Gong, Guo‐zhong;
    • Zhang, Min;
    • Xiang, Da‐xiong
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1824, doi. 10.1111/bcp.14571
    By:
    • Litzenburger, Tobias;
    • Steffgen, Jürgen;
    • Benediktus, Ewald;
    • Müller, Fabian;
    • Schultz, Armin;
    • Klein, Elliott;
    • Ramanujam, Meera;
    • Harcken, Christian;
    • Gupta, Alpana;
    • Wu, Jing;
    • Wiebe, Sabrina;
    • Li, Xiujiang;
    • Flack, Mary;
    • Padula, Steven J.;
    • Visvanathan, Sudha;
    • Hünnemeyer, Andreas;
    • Hui, Jianan
    Publication type:
    Article
    47
    48

    Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 1859, doi. 10.1111/bcp.14574
    By:
    • Almeida, Anne Cristine;
    • Elias, Anna Beatriz Ribeiro;
    • Marques, Maria Paula;
    • Melo, Gisely Cardoso;
    • Costa, Allyson Guimarães;
    • Figueiredo, Erick Frota Gomes;
    • Brasil, Larissa Wanderley;
    • Rodrigues‐Soares, Fernanda;
    • Monteiro, Wuelton Marcelo;
    • Lacerda, Marcus Vinicius Guimarães;
    • Lanchote, Vera Lucia;
    • Suarez‐Kurtz, Guilherme
    Publication type:
    Article
    49
    50